US2012276545A1PendingUtilityA1
Method for using division arrested cells in screening assays
Est. expirySep 20, 2022(expired)· nominal 20-yr term from priority
C12Q 1/025G01N 33/5011G01N 33/5041G01N 33/502G01N 33/5008G01N 33/6872
63
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Division arrested cells are used in screening assays to determine the effect of a substance of interest on the cells. The division arrested cells can be used in drug screening assays, signal transduction assays, and are especially useful in large scale, high throughput assays.
Claims
exact text as granted — not AI-modified1 . A method for determining if a substance of interest has an effect on a G-protein coupled receptor (GPCR) signal in a division arrested mammalian cell, the method comprising:
(a) contacting a division arrested mammalian cell with the substance of interest and measuring the GPCR signal in the cell, wherein the cell has been transformed or transfected with a nucleic acid encoding the GPCR, and (b) determining whether the substance of interest has an effect on the GPCR signal in the mammalian cell by identifying a comparative difference in the signal when the mammalian cell has and has not been contacted with the substance of interest.
2 - 3 . (canceled)
4 . The method of claim 1 , wherein the G-protein coupled receptor is selected from the group consisting of:
(a) a serotonin receptor; (b) a muscaranic acetylcholine receptor; and (c) a β2 adrenergic receptor.
5 . The method of claim 1 , wherein the GPCR signal measured in the mammalian cell results from Ca 2+ mobilization.
6 . The method of claim 1 , wherein the GPCR signal measured in the mammalian cell is determined by measuring the activity of a reporter.
7 . The method of claim 6 , wherein the reporter is selected from the group consisting of secreted alkaline phosphatase, luciferase, and green fluorescent protein.
8 . (canceled)
9 . The method of claim 1 , wherein the mammalian cell is a cell selected from the group consisting of:
(a) a Chinese hamster ovary cell; (b) a NIH3T3 cell; (c) a HEK293 cell; and (d) a M1WT3 cell.
10 . (canceled)
11 . The method of claim 1 , wherein the substance of interest has efficacy as a GPCR agonist.
12 . The method of claim 1 , wherein the substance of interest has efficacy as a GPCR antagonist.
13 . The method of claim 1 , wherein the division arrested mammalian cell has been frozen and thawed before contact with the substance of interest.
14 . The method of claim 1 , wherein the mammalian cell was irradiated to arrest cellular division.
15 . A composition comprising a population of mammalian cells, wherein the population is substantially uniformly division arrested and wherein the cells of the population comprise:
(i) a transformed or transfected nucleic acid encoding a G-protein coupled receptor (GPCR); (ii) the encoded GPCR; and (iii) a substance of interest, wherein the substance of interest is capable of having an effect on the activity of the GPCR.
16 . The composition of claim 15 , wherein the cells of the population are stably transformed or transfected with the nucleic acid.
17 . The composition of claim 15 , wherein the GPCR is selected from the group consisting of:
(a) a serotonin receptor; (b) a muscaranic acetylcholine receptor; and (c) a β2 adrenergic receptor.
18 . The composition of claim 15 , wherein the cells are selected from the group consisting of:
(a) Chinese hamster ovary cells (CHO); (b) NIH3T3 cells; (c) HEK293 cells; and (d) M1WT3 cells.
19 . The composition of claim 15 , wherein the substance has efficacy as a GPCR agonist.
20 . The composition of claim 15 , wherein the substance has efficacy as a GPCR antagonist.
21 . The composition of claim 15 , wherein the population of cells has been frozen and thawed before contact with the substance of interest.
22 . The composition of claim 15 , wherein the cells were irradiated to arrest cellular division.
23 . A composition comprising a population of mammalian cells, wherein the population is substantially uniformly division arrested, wherein the cells of the population are transformed or transfected with a nucleic acid encoding a G-protein coupled receptor (GPCR) and express the encoded GPCR; and
wherein the composition is frozen and the cells of the population remain in division arrest after the composition is thawed.
24 . The composition of claim 23 , wherein the cells of the population are stably transformed or transfected with the nucleic acid.
25 . The composition of claim 23 , wherein the GPCR is selected from the group consisting of:
(a) a serotonin receptor; (b) a muscaranic acetylcholine receptor; and (c) a β2 adrenergic receptor.
26 . The composition of claim 23 , wherein the cells are selected from the group consisting of:
(a) Chinese hamster ovary cells (CHO); (b) NIH3T3 cells; (c) HEK293 cells; and (d) M1WT3 cells.
27 . The composition of claim 23 , wherein the cells were irradiated to arrest cellular division.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.